Skip to content

A pan-india non-interventional virtual registry evaluating the prophylactic efficacy of different regimens against SARS-CoV2 infection (COVID-2019) in asymptomatic health care workers

A non-interventional registry evaluating the prophylactic efficacy of different regimens against SARS-CoV2 infection (COVID-2019) in asymptomatic health care workers - UNITY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/04/024482
Enrollment
10000
Registered
2020-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: NIL: NIL

Sponsors

Zifo RnD Solutions
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Asymptomatic physicians of age >= 21 years 2. Physicians must be registered with Medical Council of India (MCI) or State Medical council (e.g. https://www.mciindia.org/CMS/information-desk/indian-medical-register%20for%20India) 3. Physicians who think that by virtue of their profession, they are at risk for developing COVID 19 4. Physicians must be willing to provide data as required and willing to be contacted/ reminded about data entry at end of treatment and follow up 5. Physicians must be willing to provide contact details of a designee, who may be contacted if the physician participant is not contactable

Exclusion criteria

Exclusion criteria: Physicians who are not willing to participate in the study.

Design outcomes

Primary

MeasureTime frame
Efficacy of different prophylaxis regimens for prevention of COVID-19.Timepoint: The time point will be 7 and 9 weeks from the start of prophylaxis regimen.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactArvind Sri Krishna Mani

Zifo RnD Solutions

vis.niranjan@rxmd.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026